These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Management and outcome of Bacille Calmette-Guérin vaccine adverse reactions. Venkataraman A, Yusuff M, Liebeschuetz S, Riddell A, Prendergast AJ. Vaccine; 2015 Oct 05; 33(41):5470-5474. PubMed ID: 26275478 [Abstract] [Full Text] [Related]
6. Fifteen-minute consultation: Bacillus Calmette-Guérin abscess and lymphadenitis. Riordan A, Cole T, Broomfield C. Arch Dis Child Educ Pract Ed; 2014 Jun 05; 99(3):87-9. PubMed ID: 24212563 [No Abstract] [Full Text] [Related]
7. Safety of intradermal Bacillus Calmette-Guerin vaccine for neonates in Eastern Saudi Arabia. Al-Salem AH, Kothari MR, AlHani HM, Oquaish MM, Khogeer SS, Desouky MS. Saudi Med J; 2012 Feb 05; 33(2):172-6. PubMed ID: 22327758 [Abstract] [Full Text] [Related]
8. Management of Bacille Calmette-Guérin Lymphadenitis and Abscess in Immunocompetent Children: A Systematic Review. Villanueva P, Pittet LF, Curtis N. Pediatr Infect Dis J; 2021 Nov 01; 40(11):1037-1045. PubMed ID: 34636800 [Abstract] [Full Text] [Related]
12. [Lymphadenitis as a complication following vaccination with Bacillus Calmette-Guérin (BCG)]. Cerdá de Palou E, de Santy HP. Ned Tijdschr Geneeskd; 2003 Mar 22; 147(12):569-72. PubMed ID: 12693089 [Abstract] [Full Text] [Related]
13. The spectrum of cytological findings in patients with BCG lymphadenitis: A series of 13 cases. Vaghasiya VL, Nasit JG, Rupavatiya B, Bambhaniya DD, Kaka R. Ann Diagn Pathol; 2024 Apr 22; 69():152260. PubMed ID: 38171232 [Abstract] [Full Text] [Related]
14. Role of needle aspiration and surgical excision in management of suppurative Bacillus Calmette Guerin lymphadenitis. Naumeri F, Khan MS, Rauf A, Imran S, Tahir M. J Pak Med Assoc; 2018 Jul 22; 68(7):1120-1123. PubMed ID: 30317317 [Abstract] [Full Text] [Related]
15. The role of surgical management of BCG vaccine-induced regional suppurative lymphadenitis in children: a 7 years' experience from one medical center. Liu C, Huang M, Liu F, Xu X, Feng W, Han G, Liu X, Zheng B, Geng L, Fu T. BMC Infect Dis; 2021 Aug 11; 21(1):801. PubMed ID: 34380453 [Abstract] [Full Text] [Related]
16. Clinical features and outcomes of Bacille Calmette-Guérin (BCG)-induced diseases following neonatal BCG Tokyo-172 strain immunization. Rermruay R, Rungmaitree S, Chatpornvorarux S, Brukesawan C, Wittawatmongkol O, Lapphra K, Phongsamart W, Kongstan N, Khumcha B, Chokephaibulkit K. Vaccine; 2018 Jun 27; 36(28):4046-4053. PubMed ID: 29859799 [Abstract] [Full Text] [Related]
17. [Clinical aspect and therapy of BCG-lymphadenitis (author's transl)]. Lachmann D, Howanietz L. Padiatr Padol; 1976 Jun 27; 11(1):283-6. PubMed ID: 1250626 [Abstract] [Full Text] [Related]
18. Adverse reactions to the Bacillus Calmette-Guérin (BCG) vaccine in new-born infants-an evaluation of the Danish strain 1331 SSI in a randomized clinical trial. Nissen TN, Birk NM, Kjærgaard J, Thøstesen LM, Pihl GT, Hoffmann T, Jeppesen DL, Kofoed PE, Greisen G, Benn CS, Aaby P, Pryds O, Stensballe LG. Vaccine; 2016 May 11; 34(22):2477-82. PubMed ID: 27060379 [Abstract] [Full Text] [Related]